Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy response.

bioRxiv : the preprint server for biology·2026
Same author

Lung Metastasis From Chronic Lymphocytic Leukemia.

Annals of thoracic surgery short reports·2026
Same author

Discoid Lupus Erythematosus in Genital Skin: A Case Report and Review of the Literature.

Journal of cutaneous pathology·2026
Same author

IL-13 and calpain-14 suppress the expression of SPINK7 by regulating OVOL1 in eosinophilic esophagitis.

JCI insight·2026
Same author

Machine learning-predicted chromatin organization landscape across pediatric tumors.

Scientific reports·2026
Same author

Cooperativity in E. coli aspartate transcarbamoylase is tuned by allosteric breathing.

Nature communications·2026
Same journal

Postoperative adjuvant eribulin in high-risk patients with soft tissue sarcoma: A retrospective study of eight cases.

Rare tumors·2026
Same journal

Palatal malignant peripheral nerve sheath tumor: A case report and review of literature.

Rare tumors·2026
Same journal

Durable remission of metastatic myxoid liposarcoma following the cautious addition of pembrolizumab to ongoing pazopanib treatment: A case report.

Rare tumors·2026
Same journal

Diagnostic utility of Ki-67 proliferation index, PSA, and other immunohistochemical markers in prostatic basal cell carcinoma: A review of 24 cases in the current literature and discussion on current treatment and diagnostics.

Rare tumors·2026
Same journal

Chronic myeloid leukemia presenting with isolated central nervous system lymphoid blast crisis: A case report.

Rare tumors·2026
Same journal

Bronchoscopy, surgery and radiation therapy for bronchial adenoid cystic carcinoma: A retrospective cohort study.

Rare tumors·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K

Langerhan's Cell Sarcoma: Two Case Reports.

Tasneem A Kaleem1, Michael H Schild1, Daniel Miller1

  • 1Department of Radiation Oncology, Mayo Clinic Florida , Jacksonville, FL, USA.

Rare Tumors
|May 3, 2016
PubMed
Summary
This summary is machine-generated.

Langerhan's cell sarcoma (LCS) is a rare cancer. This study presents two distinct LCS cases, highlighting varied presentations and treatment responses for this aggressive neoplasm.

Keywords:
Langerhan’sMedicinecanceroncologyraresarcomatumor

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
07:10

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

19.2K

Related Experiment Videos

Last Updated: Mar 21, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
07:10

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

19.2K

Area of Science:

  • Oncology
  • Pathology

Background:

  • Langerhan's cell sarcoma (LCS) is an exceptionally rare neoplasm.
  • Published cases of LCS are limited, with only sixty-six documented instances.

Observation:

  • Two distinct LCS patient cases are presented, showcasing divergent clinical presentations.
  • Case 1: A patient with a history of high-grade myxofibrosarcomas presented with a solitary LCS skin lesion, treated with resection and radiotherapy, experiencing locoregional recurrence.
  • Case 2: A patient presented with bone marrow and splenic involvement, leukocytosis, and thrombocytopenia.

Findings:

  • Case 1 patient remains alive two years post-diagnosis after repeated resection for locoregional recurrence.
  • Case 2 patient achieved a complete remission with combination chemotherapy (etoposide, prednisone, oncovorin, cyclophosphamide, adriamycin), normalization of blood counts, and successful splenectomy.

Implications:

  • The varied presentations underscore the diagnostic challenges of LCS.
  • Successful treatment strategies may involve multimodal approaches tailored to individual patient disease burden and characteristics.
  • Further research into LCS pathogenesis and treatment is warranted given its rarity and poor prognosis.